GlassScriptPhysician profile
Hasan Faheem Dani
NPI 1902337066
$4,127.97
in general payments reported to CMS, 2019-2025
27 companies · $935 in 2025
The $935 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2023: $275 · 2024: $2,797 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,556 · Travel and Lodging: $1,433 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,555.76 |
| Travel and Lodging | $1,433.00 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $1,697.00 | 2024 | |
| Janssen Biotech, INC. | $426.53 | 2024-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $283.71 | 2023-2025 | Botox |
| Merck Sharp & Dohme LLC | $207.27 | 2023-2025 | Lynparza, Keytruda |
| Astellas Pharma US INC | $206.76 | 2021-2025 | Myrbetriq, Veozah, Xtandi |
| Accord Healthcare, INC. | $159.19 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $129.65 | 2024-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $129.33 | 2023-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $117.88 | 2024-2025 | Provenge |
| Intuitive Surgical, INC. | $96.23 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.80 | 2023-2025 | |
| Endo USA, INC. | $78.84 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $64.99 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $62.17 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $59.67 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $39.31 | 2025 | Revi |
| Coloplast Corp | $38.84 | 2021 | |
| Immunitybio, INC. | $37.89 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $34.29 | 2023-2025 | Lynparza |
| Tempus Ai, INC | $29.59 | 2024 | |
| Tolmar, INC. | $29.20 | 2023 | |
| Janssen Scientific Affairs, LLC | $28.13 | 2024 | Erleada |
| Sun Pharmaceutical Industries INC. | $19.76 | 2024 | |
| Bioprotect Medical, INC. | $18.93 | 2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $17.57 | 2023 | Xiaflex |
| Ethicon US, LLC | $16.72 | 2025 | Echelon Circular |
| Srs Medical Systems, INC. | $15.72 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Dani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.